News

Public · Published

Alchemy Forms ITB Consortium with Navim Group and Surface Science Western to Advance Crypsis(TM) for Naval and Maritime Coatings

Alchemy Labs entered a consortium agreement with Navim Group to develop and integrate its Crypsis thermal signature management technology into naval and maritime coatings. Navim agreed to fund half of an approximately €414,000 research and development project; Alchemy will fund the other half and lead development, with Surface Science Western expected to provide testing support.

Published:

Updated:

What happened

Alchemy Labs entered a consortium agreement with Navim Group to develop and integrate its Crypsis thermal signature management technology into naval and maritime coatings. Navim agreed to fund half of an approximately €414,000 research and development project; Alchemy will fund the other half and lead development, with Surface Science Western expected to provide testing support.

Confirmed

Global impact / market context

The project gives Alchemy a funded route to test whether its technology can be incorporated into sprayable maritime coatings. If development succeeds, it could support future sales to naval or maritime customers, while Alchemy must contribute half the project cost before any such revenue is established.

Analyst inference

The work is linked to Navim’s obligations under Canada’s Industrial and Technological Benefits Policy and its participation in Seaspan Shipyards’ work under the National Shipbuilding Strategy. This connects research funding to shipbuilding activity, but the article reports a development project, not a contract for commercial supply.

Confirmed

What to watch

  1. Watch for results showing whether Crypsis can be integrated into sprayable coatings for hard surfaces; the supplied article text ends before giving further project details. Analyst inference
  2. Watch for confirmation of Surface Science Western’s testing role and any reported findings, since its support is described as expected rather than completed. Analyst inference
  3. Watch whether the research leads to a commercial supply agreement or follow-on funding; neither is announced in the supplied article text. Analyst inference

Evidence